Genentech, Inc. - Company & Market Research Reports

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

Remicade Biosimilar Market: By Type, By Technology, By Service, By Application, By Region - Forecast 2016-2021 - Product Thumbnail Image

Remicade Biosimilar Market: By Type, By Technology, By Service, By Application, By Region - Forecast 2016-2021

  • Report
  • 146 Pages
From
Drug analysis: Avastin - Product Thumbnail Image

Drug analysis: Avastin

  • Drug Pipelines
  • 116 Pages
From
Competitor Analysis: VEGF Antibodies – Bevacizumab and Ranibizumab Biosimilars and Biosuperiors - Product Thumbnail Image

Competitor Analysis: VEGF Antibodies – Bevacizumab and Ranibizumab Biosimilars and Biosuperiors

  • Report
  • 70 Pages
From
Avastin 2017 U.S. Promotional Audit Report - Product Thumbnail Image

Avastin 2017 U.S. Promotional Audit Report

  • Report
  • 25 Pages
From
Rituxan 2017 U.S. Promotional Audit Report - Product Thumbnail Image

Rituxan 2017 U.S. Promotional Audit Report

  • Report
  • 27 Pages
From
Investigation Report on China's Bevacizumab Market ,2010-2019 - Product Thumbnail Image

Investigation Report on China's Bevacizumab Market ,2010-2019

  • Report
  • 20 Pages
From
Bladder and Ureter Cancer Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Bladder and Ureter Cancer Drug Development Pipeline Review, 2017

  • Report
  • 150 Pages
From
Global Regenerative Medicine Market Analysis & Forecast to 2021 - Stem Cells, Tissue Engineering, BioBanking & CAR-T Industries - Product Thumbnail Image

Global Regenerative Medicine Market Analysis & Forecast to 2021 - Stem Cells, Tissue Engineering, BioBanking & CAR-T Industries

  • Drug Pipelines
  • 682 Pages
From
Investigation Report on China Bevacizumab Market, 2009-2018 - Product Thumbnail Image

Investigation Report on China Bevacizumab Market, 2009-2018

  • Report
  • 40 Pages
From
Global Regenerative Medicine Market Analysis & Forecast to 2022; Stem Cells, Tissue Engineering, BioBanking & CAR-T Industries - Product Thumbnail Image

Global Regenerative Medicine Market Analysis & Forecast to 2022; Stem Cells, Tissue Engineering, BioBanking & CAR-T Industries

  • Report
  • 682 Pages
From
Tarceva 2017 U.S. Promotional Audit Report - Product Thumbnail Image

Tarceva 2017 U.S. Promotional Audit Report

  • Report
  • 21 Pages
From
Digital Health Market: Focus on Digital Therapeutic, Monitoring and Diagnostic Solutions, 2018-2030 - Product Thumbnail Image

Digital Health Market: Focus on Digital Therapeutic, Monitoring and Diagnostic Solutions, 2018-2030

  • Report
  • 432 Pages
From
Drugs and Diagnostics for Hematological Disorders: Global Markets - Product Thumbnail Image

Drugs and Diagnostics for Hematological Disorders: Global Markets

  • Report
  • 504 Pages
From
Investigation Report on China Adalimumab Market, 2010-2018 - Product Thumbnail Image

Investigation Report on China Adalimumab Market, 2010-2018

  • Report
  • 40 Pages
From
Stroke Diagnostics and Therapeutics - Global Market Outlook (2017-2026) - Product Thumbnail Image

Stroke Diagnostics and Therapeutics - Global Market Outlook (2017-2026)

  • Report
  • 188 Pages
From
Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Pipeline Review, H2 2018 - Product Thumbnail Image

Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Pipeline Review, H2 2018

  • Drug Pipelines
  • 51 Pages
From
Monoclonal Antibodies - Global Trends in the Competitive, Technological and R&D Landscape - Product Thumbnail Image

Monoclonal Antibodies - Global Trends in the Competitive, Technological and R&D Landscape

  • Report
  • 57 Pages
From
 What's Trending in Monoclonal Antibodies (Market by Structure [Chimeric, Humanized], by Target [EGFR, TNF, HER2, CD20,PD-1, Other] and by Disease [Autoimmune, Oncology, Neurological, Other]) - Product Thumbnail Image

What's Trending in Monoclonal Antibodies (Market by Structure [Chimeric, Humanized], by Target [EGFR, TNF, HER2, CD20,PD-1, Other] and by Disease [Autoimmune, Oncology, Neurological, Other])

  • Report
  • 203 Pages
From
Global Bladder Cancer Market Research and Forecast 2018-2023 - Product Thumbnail Image

Global Bladder Cancer Market Research and Forecast 2018-2023

  • Report
From
Systemic Lupus Erythematosus Pipeline Analysis, 2017 - Product Thumbnail Image

Systemic Lupus Erythematosus Pipeline Analysis, 2017

  • Report
  • 172 Pages
From
Loading Indicator
adroll